Cell death and diseases related to oxidative stress:4-hydroxynonenal (HNE) in the balance

Cell Death and Differentiation

Volumn 20, Issue 12, 2013, Pages 1615-1630

  Dalleau, S ^a,b   Baradat, M ^a,b   Gueraud F ^a,b   Huc, L ^a,b  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

apoptosis; detoxification; Lipoperoxidation; oxidative stress; protein adduct

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; CALPAIN; FAS ANTIGEN; FERRITIN; IRON; JANUS KINASE; PROTEASOME; PROTEIN P53; TRANSCRIPTION FACTOR NRF2;

ALZHEIMER DISEASE; APOPTOSIS; ATHEROSCLEROSIS; AUTOPHAGY; CARDIOVASCULAR DISEASE; CELL AGING; CELL CYCLE ARREST; CELL DEATH; CELL FATE; CELL METABOLISM; CELL STRESS; CELL SURVIVAL; CHEMOREACTIVITY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; GENOTOXICITY; HUMAN; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LIVER DISEASE; METABOLIC SYNDROME X; NEOPLASM; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PLEIOTROPY; PRIORITY JOURNAL; REVIEW;

ALDEHYDES; ANIMALS; CELL DEATH; DISEASE; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84887620267     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.138     Document Type: Review

References (160)

1. Schaur RJ. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 2003; 24: 149-159. (Pubitemid 36945015)
2. Duryee MJ, Willis MS, Freeman TL, Kuszynski CA, Tuma DJ, Klassen LW et al. Mechanisms of alcohol liver damage: Aldehydes, scavenger receptors, and autoimmunity. Front Bio sci 2004; 9: 3145-3155.
3. Poli G, Schaur RJ, Siems WG, Leonarduzzi G. 4-hydroxynonenal: A membrane lipid oxidation product of medicinal interest. Med Res Rev 2008; 28: 569-631. (Pubitemid 351842143)
4. Uchida K, Toyokuni S, Nishikawa K, Kawakishi S, Oda H, Hiai H et al. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: Markers for atherosclerosis. Biochemistry 1994; 33: 12487-12494. (Pubitemid 24340455)
5. Pierre F, Peiro G, Tache S, Cross AJ, Bingham SA, Gasc N et al. New marker of colon cancer risk associated with heme intake: 1,4-dihydroxynonane mercapturic acid. Cancer Epidemiol Biomarkers Prev 2006; 15: 2274-2279. (Pubitemid 44877056)
6. Wang X, Yang Y, Moore DR, Nimmo SL, Lightfoot SA, Huycke MM. 4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. Gastroenterology 2012; 142: 543-551 e7.
7. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128. (Pubitemid 121003917)
8. Parola M, Bellomo G, Robino G, Barrera G, Dianzani MU. 4-Hydroxynonenal as a biological signal: Molecular basis and pathophysiological implications. Antioxid Redox Signal 1999; 1: 255-284. (Pubitemid 129622798)
9. Dwivedi S, Sharma A, Patrick B, Sharma R, Awasthi YC. Role of 4-hydroxynonenal and its metabolites in signaling. Redox Rep 2007; 12: 4-10. (Pubitemid 46210346)
10. Smathers RL, Fritz KS, Galligan JJ, Shearn CT, Reigan P, Marks MJ et al. Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics. PLoS One 2012; 7: E38459.
11. Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, Esterbauer H et al. Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med 1997; 23: 357-360. (Pubitemid 27276770)
12. Siems WG, Brenke R, Beier A, Grune T. Oxidative stress in chronic lymphoedema. QJM 2002; 95: 803-809. (Pubitemid 36032950)
13. SiemsW, Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 2003; 24: 167-175.
14. Baradat M, Jouanin I, Dalleau S, Tache S, Gieules M, Debrauwer L et al. 4-Hydroxy-2(E)-nonenal metabolism differs in Apc(/) cells and in Apc(Min/) cells: It may explain colon cancer promotion by heme iron. Chem Res Toxicol 2011; 24: 1984-1993.
15. Siems WG, Zollner H, Grune T, Esterbauer H. Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. J Lipid Res 1997; 38: 612-622. (Pubitemid 27166704)
16. Chiarpotto E, Domenicotti C, Paola D, Vitali A, Nitti M, Pronzato MA et al. Regulation of rat hepatocyte protein kinase C beta isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: A signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 1999; 29: 1565-1572. (Pubitemid 29211062)
17. Zhang H, Forman HJ. Signaling pathways involved in phase II gene induction by alpha, beta-unsaturated aldehydes. Toxicol Ind Health 2009; 25: 269-278.
18. Pettazzoni P, Ciamporcero E, Medana C, Pizzimenti S, Dal Bello F, Minero VG et al. Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells. Free Radic Biol Med 2011; 51: 1610-1618.
19. Patrick B, Li J, Jeyabal PV, Reddy PM, Yang Y, Sharma R et al. Depletion of 4-hydroxynonenal in hGSTA4-transfected HLE B-3 cells results in profound changes in gene expression. Biochem Biophys Res Commun 2005; 334: 425-432. (Pubitemid 40982385)
20. Grune T, Davies KJ. The proteasomal system and HNE-modified proteins. Mol Aspects Med 2003; 24: 195-204. (Pubitemid 36945019)
21. Zarkovic K. 4-hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 2003; 24: 293-303. (Pubitemid 36945029)
22. Choudhary S, Xiao T, Srivastava S, Zhang W, Chan LL, Vergara La et al. Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol Appl Pharmacol 2005; 204: 122-134. (Pubitemid 40432370)
23. Negre-Salvayre A, Vieira O, Escargueil-Blanc I, Salvayre R. Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity. Mol Aspects Med 2003; 24: 251-261. (Pubitemid 36945025)
24. Mattson MP. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 2009; 44: 625-633.
25. Karihtala P, Kauppila S, Puistola U, Jukkola-Vuorinen A. Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis. Histopathology 2011; 58: 854-862.
26. Perry EA, Castellani RJ, Moreira PI, Nunomura A, Lui Q, Harris PL et al. Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links. Free Radic Res 2013; 47: 507-510.
27. Butterfield DA, Swomley AM, Sultana R. Amyloid beta-peptide (1-42)-induced oxidative stress in alzheimer disease: Importance in disease pathogenesis and progression. Antioxid Redox Signal 2013; 19: 823-835.
28. Shringarpure R, Grune T, Sitte N, Davies KJ. 4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: Possible importance in Alzheimers disease. Cell Mol Life Sci 2000; 57: 1802-1809.
29. Rockwell P, Yuan H, Magnusson R, Figueiredo-Pereira ME. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2). Arch Biochem Biophys 2000; 374: 325-333. (Pubitemid 30120269)
30. Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 1997; 69: 273-284. (Pubitemid 27274182)
31. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 1997; 68: 255-264. (Pubitemid 26427315)
32. Jenner P. Oxidative stress in Parkinsons disease. Ann Neurol 2003; 53(Suppl 3): S26-S36; discussion S36-8.
33. Morel P, Tallineau C, Pontcharraud R, Piriou A, Huguet F. Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na/K ATPase in rat striatal synaptosomes. Neurochem Int 1998; 33: 531-540. (Pubitemid 29116229)
34. Westerlund M, Galter D, Carmine A, Olson L. Tissue-and species-specific expression patterns of class I, III, and IV Adh and Aldh 1 mRNAs in rodent embryos. Cell Tissue Res 2005; 322: 227-236. (Pubitemid 41679400)
35. Al Nimer F, Strom M, Lindblom R, Aeinehband S, Bellander BM, Nyengaard JR et al. Naturally occurring variation in the glutathione-s-transferase 4 gene determines neurodegeneration after traumatic brain injury. Antioxid Redox Signal 2013; 18: 784-794.
36. Hipkiss AR. Carnosine and its possible roles in nutrition and health. Adv Food Nutr Res 2009; 57: 87-154.
37. Hegyi L, Skepper JN, Cary NR, Mitchinson MJ. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol 1996; 180: 423-429.
38. Vindis C, Escargueil-Blanc I, Elbaz M, Marcheix B, Grazide MH, Uchida K et al. Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: Prevention by aldehyde scavengers. Circ Res 2006; 98: 785-792.
39. Leonarduzzi G, Chiarpotto E, Biasi F, Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 2005; 49: 1044-1049. (Pubitemid 41735564)
40. Herbst U, Toborek M, Kaiser S, Mattson MP, Hennig B. 4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells. J Cell Physiol 1999; 181: 295-303. (Pubitemid 29463644)
41. Hajjar DP, Haberland ME. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J Biol Chem 1997; 272: 22975-22978. (Pubitemid 27392417)
42. VanWinkle WB, Snuggs M, Miller JC, Buja LM. Cytoskeletal alterations in cultured cardiomyocytes following exposure to the lipid peroxidation product, 4-hydroxynonenal. Cell Motil Cytoskeleton 1994; 28: 119-134. (Pubitemid 24176930)
43. Singh R, Wang Y, Schattenberg JM, Xiang Y, Czaja MJ. Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation. Am J Physiol Gastrointest Liver Physiol 2009; 297: G907-G917.
44. Mottaran E, Stewart SF, Rolla R, Vay D, Cipriani V, Moretti M et al. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic Biol Med 2002; 32: 38-45. (Pubitemid 34045135)
45. Dou X, Li S, Wang Z, Gu D, Shen C, Yao T et al. Inhibition of NF-kappaB activation by 4-hydroxynonenal contributes to liver injury in a mouse model of alcoholic liver disease. Am J Pathol 2012; 181: 1702-1710.
46. Valentovic M, Terneus M, Harmon RC, Carpenter AB. S-Adenosylmethionine (SAMe) attenuates acetaminophen hepatotoxicity in C57BL/6 mice. Toxicol Lett 2004; 154: 165-174. (Pubitemid 39389083)
47. Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 2012; 2012: 137289.
48. Cheeseman KH, Burton GW, Ingold KU, Slater TF. Lipid peroxidation and lipid antioxidants in normal and tumor cells. Toxicol Pathol 1984; 12: 235-239. (Pubitemid 15175920)
49. Tjalkens RB, Cook LW, Petersen DR. Formation and export of the glutathione conjugate of 4-hydroxy-2, 3-E-nonenal (4-HNE) in hepatoma cells. Arch Biochem Biophys 1999; 361: 113-119. (Pubitemid 29393721)
50. Oberley TD, Toyokuni S, Szweda LI. Localization of hydroxynonenal protein adducts in normal human kidney and selected human kidney cancers. Free Radic Biol Med 1999; 27: 695-703. (Pubitemid 29408656)
51. Biasi F, Tessitore L, Zanetti D, Cutrin JC, Zingaro B, Chiarpotto E et al. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression. Gut 2002; 50: 361-367. (Pubitemid 34161052)
52. Skrzydlewska E, Stankiewicz A, Sulkowska M, Sulkowski S, Kasacka I. Antioxidant status and lipid peroxidation in colorectal cancer. J Toxicol Environ Health A 2001; 64: 213-222. (Pubitemid 32929955)
53. Young O, Crotty T, OConnell R, OSullivan J, Curran AJ. Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck 2010; 32: 750-756.
54. Juric-Sekhar G, Zarkovic K, Waeg G, Cipak A, Zarkovic N. Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain. Tumori 2009; 95: 762-768.
55. Marquez-Quinones A, Cipak A, Zarkovic K, Fattel-Fazenda S, Villa-Trevino S, Waeg G et al. HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res 2010; 44: 119-127.
56. Dianzani MU. Lipid peroxidation and cancer: A critical reconsideration. Tumori 1989; 75: 351-357.
57. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K et al. Oncogeneinduced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011; 475: 106-109.
58. Dianzani MU. Lipid peroxidation and cancer. Crit Rev Oncol Hematol 1993; 15: 125-147. (Pubitemid 24013566)
59. Pierre F, Tache S, Gueraud F, Rerole AL, Jourdan ML, Petit C. Apc mutation induces resistance of colonic cells to lipoperoxide-triggered apoptosis induced by faecal water from haem-fed rats. Carcinogenesis 2007; 28: 321-327. (Pubitemid 46321847)
60. Feng Z, Hu W, Amin S, Tang MS. Mutational spectrum and genotoxicity of the major lipid peroxidation product, trans-4-hydroxy-2-nonenal, induced DNA adducts in nucleotide excision repair-proficient and-deficient human cells. Biochemistry 2003; 42: 7848-7854. (Pubitemid 36758950)
61. Hu W, Feng Z, Eveleigh J, Iyer G, Pan J, Amin S et al. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 2002; 23: 1781-1789. (Pubitemid 35355927)
62. Feng Z, Hu W, Tang MS. Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: A possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci USA 2004; 101: 8598-8602. (Pubitemid 38745816)
63. Cheng JZ, Sharma R, Yang Y, Singhal SS, Sharma A, Saini MK et al. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem 2001; 276: 41213-41223.
64. Yang Y, Sharma A, Sharma R, Patrick B, Singhal SS, Zimniak P et al. Cells preconditioned with mild, transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis: Role of 4-hydroxynonenal in UVA-mediated signaling for apoptosis. J Biol Chem 2003; 278: 41380-41388. (Pubitemid 37280967)
65. Ramachandran V, Watts LT, Maffi SK, Chen J, Schenker S, Henderson G. Ethanolinduced oxidative stress precedes mitochondrially mediated apoptotic death of cultured fetal cortical neurons. J Neurosci Res 2003; 74: 577-588. (Pubitemid 37352080)
66. Wallach D, Kang TB, Kovalenko A. The extrinsic cell death pathway and the elan mortel. Cell Death Differ 2008; 15: 1533-1541.
67. Li J, Sharma R, Patrick B, Sharma A, Jeyabal PV, Reddy PM et al. Regulation of CD95 (Fas) expression and Fas-mediated apoptotic signaling in HLE B-3 cells by 4-hydroxynonenal. Biochemistry 2006; 45: 12253-12264. (Pubitemid 44527548)
68. Engle MR, Singh SP, Czernik PJ, Gaddy D, Montague DC, Ceci JD et al. Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: Generation and analysis of mGsta4 null mouse. Toxicol Appl Pharmacol 2004; 194: 296-308. (Pubitemid 38180461)
69. Sharma R, Sharma A, Dwivedi S, Zimniak P, Awasthi S, Awasthi YC. 4-Hydroxynonenal self-limits fas-mediated DISC-independent apoptosis by promoting export of Daxx from the nucleus to the cytosol and its binding to Fas. Biochemistry 2008; 47: 143-156.
70. Salomoni P, Khelifi AF. Daxx: Death or survival protein Trends Cell Biol 2006; 16: 97-104.
71. Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997; 89: 1067-1076. (Pubitemid 127678740)
72. Singh SP, Niemczyk M, Saini D, Sadovov V, Zimniak L, Zimniak P. Disruption of the mGsta4 gene increases life span of C57BL mice. J Gerontol A Biol Sci Med Sci 2010; 65: 14-23.
73. Torii S, Egan DA, Evans RA, Reed JC. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J 1999; 18: 6037-6049. (Pubitemid 29515680)
74. West JD, Marnett LJ. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chem Res Toxicol 2005; 18: 1642-1653. (Pubitemid 43257745)
75. Weigel AL, Handa JT, Hjelmeland LM. Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med 2002; 33: 1419-1432. (Pubitemid 35284925)
76. Marchette LD, Wang H, Li F, Babizhayev MA, Kasus-Jacobi A. Carcinine has 4-hydroxynonenal scavenging property and neuroprotective effect in mouse retina. Invest Ophthalmol Vis Sci 53: 3572-3583.
77. Battisti V, Maders LD, Bagatini MD, Santos KF, Spanevello RM, Maldonado PA et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin Biochem 2008; 41: 511-518.
78. Khanna S, Sen CK, Roy S, Christen MO, Packer L. Protective effects of anethole dithiolethione against oxidative stress-induced cytotoxicity in human Jurkat T cells. Biochem Pharmacol 1998; 56: 61-69. (Pubitemid 28477452)
79. Galluzzi L, Joza N, Tasdemir E, Maiuri MC, Hengartner M, Abrams JM et al. No death without life: Vital functions of apoptotic effectors. Cell Death Differ 2008; 15: 1113-1123. (Pubitemid 351850963)
80. Haynes RL, Brune B, Townsend AJ. Apoptosis in RAW 264.7 cells exposed to 4-hydroxy-2-nonenal: Dependence on cytochrome C release but not p53 accumulation. Free Radic Biol Med 2001; 30: 884-894. (Pubitemid 32289266)
81. Braga M, Sinha Hikim AP, Datta S, Ferrini MG, Brown D, Kovacheva EL et al. Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis 2008; 13: 822-832.
82. Ji C, Amarnath V, Pietenpol JA, Marnett LJ. 4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release. Chem Res Toxicol 2001; 14: 1090-1096. (Pubitemid 32800165)
83. Siddiqui MA, Kumar V, Kashyap MP, Agarwal M, Singh AK, Khanna VK et al. Short-term exposure of 4-hydroxynonenal induces mitochondria-mediated apoptosis in PC12 cells. Hum Exp Toxicol 2012; 31: 336-345.
84. Hill BG, Dranka BP, Zou L, Chatham JC, Darley-Usmar VM. Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. Biochem J 2009; 424: 99-107.
85. Bodur C, Kutuk O, Tezil T, Basaga H. Inactivation of Bcl-2 through IkappaB kinase (IKK)-dependent phosphorylation mediates apoptosis upon exposure to 4-hydroxynonenal (HNE). J Cell Physiol 2012; 227: 3556-3565.
86. Liu W, Porter NA, Schneider C, Brash AR, Yin H. Formation of 4-hydroxynonenal from cardiolipin oxidation: Intramolecular peroxyl radical addition and decomposition. Free Radic Biol Med 2011; 50: 166-178.
87. Raza H, John A. 4-hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol Appl Pharmacol 2006; 216: 309-318. (Pubitemid 44466011)
88. Liu W, Kato M, Akhand AA, Hayakawa A, Suzuki H, Miyata T et al. 4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J Cell Sci 2000; 113(Pt 4): 635-641. (Pubitemid 30133041)
89. Lee JY, Jung GY, Heo HJ, Yun MR, Park JY, Bae SS et al. 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicol Lett 2006; 166: 212-221. (Pubitemid 44416551)
90. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 1999; 274: 2234-2242.
91. Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene 2008; 27: 6245-6251.
92. Parola M, Robino G, Marra F, Pinzani M, Bellomo G, Leonarduzzi G et al. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest 1998; 102: 1942-1950. (Pubitemid 29001840)
93. Song BJ, Soh Y, Bae M, Pie J, Wan J, Jeong K. Apoptosis of PC12 cells by 4-hydroxy-2-nonenal is mediated through selective activation of the c-Jun N-terminal protein kinase pathway. Chem Biol Interact 2001; 130-132: 943-954. (Pubitemid 32295877)
94. Kutuk O, Basaga H. Apoptosis signalling by 4-hydroxynonenal: A role for JNK-c-Jun/AP-1 pathway. Redox Rep 2007; 12: 30-34. (Pubitemid 46210351)
95. Bruckner SR, Estus S. JNK3 contributes to c-jun induction and apoptosis in 4-hydroxynonenal-treated sympathetic neurons. J Neurosci Res 2002; 70: 665-670. (Pubitemid 35397140)
96. Kutuk O, Poli G, Basaga H. Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling. Toxicol Sci 2006; 90: 120-132. (Pubitemid 43264732)
97. Jang YJ, Kim JE, Kang NJ, Lee KW, Lee HJ. Piceatannol attenuates 4-hydroxynonenalinduced apoptosis of PC12 cells by blocking activation of c-Jun N-terminal kinase. Ann N Y Acad Sci 2009; 1171: 176-182.
98. Sharma A, Sharma R, Chaudhary P, Vatsyayan R, Pearce V, Jeyabal PV et al. 4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells. Arch Biochem Biophys 2008; 480: 85-94.
99. Knoll N, Ruhe C, Veeriah S, Sauer J, Glei M, Gallagher EP et al. Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate. Toxicol Sci 2005; 86: 27-35. (Pubitemid 41511346)
100. Eckl PM. Genotoxicity of HNE. Mol Aspects Med 2003; 24: 161-165. (Pubitemid 36945016)
101. Buizza L, Prandelli C, Bonini SA, Delbarba A, Cenini G, Lanni C et al. Conformational altered p53 affects neuronal function: Relevance for the response to toxic insult and growth-associated protein 43 expression. Cell Death Dis 2013; 4: E484.
102. Barone E, Cenini G, Sultana R, Di Domenico F, Fiorini A, Perluigi M et al. Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B. Antioxid Redox Signal 2012; 16: 1407-1420.
103. Cenini G, Sultana R, Memo M, Butterfield DA. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimers disease. J Cell Mol Med 2008; 12: 987-994. (Pubitemid 351718076)
104. Choudhary S, Zhang W, Zhou F, Campbell GA, Chan LL, Thompson EB et al. Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells. Free Radic Biol Med 2002; 32: 360-369. (Pubitemid 34159090)
105. Kruman II, Mattson MP. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J Neurochem 1999; 72: 529-540. (Pubitemid 29055214)
106. Peng ZF, Koh CH, Li QT, Manikandan J, Melendez AJ, Tang SY et al. Deciphering the mechanism of HNE-induced apoptosis in cultured murine cortical neurons: Transcriptional responses and cellular pathways. Neuropharmacology 2007; 53: 687-698. (Pubitemid 47513174)
107. Chaudhary P, Sharma R, Sharma A, Vatsyayan R, Yadav S, Singhal SS et al. Mechanisms of 4-hydroxy-2-nonenal induced pro-and anti-apoptotic signaling. Biochemistry 2010; 49: 6263-6275.
108. Ferrington DA, Kapphahn RJ. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett 2004; 578: 217-223. (Pubitemid 39601784)
109. Vladykovskaya E, Sithu SD, Haberzettl P, Wickramasinghe NS, Merchant ML, Hill BG et al. Lipid peroxidation product 4-hydroxy-trans-2-nonenal causes endothelial activation by inducing endoplasmic reticulum stress. J Biol Chem 2012; 287: 11398-11409.
110. Muller C, Bandemer J, Vindis C, Camare C, Mucher E, Gueraud F et al. Protein disulfide isomerase modification and inhibition contribute to er stress and apoptosis induced by oxidized low density lipoproteins. Antioxid Redox Signal 2013; 18: 731-742.
111. Santos CX, Tanaka LY, Wosniak J, Laurindo FR. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: Roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 2009; 11: 2409-2427.
112. Sovic A, Borovic S, Loncaric I, Kreuzer T, Zarkovic K, Vukovic T et al. The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins. Anticancer Res 2001; 21: 1997-2004. (Pubitemid 32728942)
113. Bresgen N, Jaksch H, Lacher H, Ohlenschlager I, Uchida K, Eckl PM. Iron mediated oxidative stress plays an essential role in ferritin induced cell death. Free Radic Biol Med 2010; 48: 1347-1357.
114. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 2012; 149: 1060-1072.
115. Green DR, Victor B. The pantheon of the fallen: Why are there so many forms of cell death Trends Cell Biol 2012; 22: 555-556.
116. Jacobs AT, Marnett LJ. Heat shock factor 1 attenuates 4-hydroxynonenal-mediated apoptosis: Critical role for heat shock protein 70 induction and stabilization of Bcl-XL. J Biol Chem 2007; 282: 33412-33420. (Pubitemid 350159530)
117. Jacobs AT, Marnett LJ. HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J Biol Chem 2009; 284: 9176-9183.
118. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003; 36: 131-149. (Pubitemid 36808270)
119. Barrera G, Pizzimenti S, Laurora S, Briatore F, Toaldo C, Dianzani MU. 4-hydroxynonenal and cell cycle. Biofactors 2005; 24: 151-157. (Pubitemid 41750538)
120. Pizzimenti S, Barrera G, Dianzani MU, Brusselbach S. Inhibition of D1, D2, and A-cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal. Free Radic Biol Med 1999; 26: 1578-1586. (Pubitemid 29302291)
121. Wonisch W, Kohlwein SD, Schaur J, Tatzber F, Guttenberger H, Zarkovic N et al. Treatment of the budding yeast Saccharomyces cerevisiae with the lipid peroxidation product 4-HNE provokes a temporary cell cycle arrest in G1 phase. Free Radic Biol Med 1998; 25: 682-687. (Pubitemid 28464934)
122. Pettazzoni P, Pizzimenti S, Toaldo C, Sotomayor P, Tagliavacca L, Liu S et al. Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. Free Radic Biol Med 50: 313-322.
123. Laurora S, Tamagno E, Briatore F, Bardini P, Pizzimenti S, Toaldo C et al. 4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. Free Radic Biol Med 2005; 38: 215-225. (Pubitemid 39656132)
124. Ahmed EK, Rogowska-Wrzesinska A, Roepstorff P, Bulteau AL, Friguet B. Protein modification and replicative senescence of WI-38 human embryonic fibroblasts. Aging Cell 2010; 9: 252-272.
125. Voghel G, Thorin-Trescases N, Farhat N, Mamarbachi AM, Villeneuve L, Fortier A et al. Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mech Ageing Dev 2008; 129: 261-270.
126. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
127. Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344. (Pubitemid 34756516)
128. Pizzimenti S, Menegatti E, Berardi D, Toaldo C, Pettazzoni P, Minelli R et al. 4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity. J Nutr Biochem 2010; 21: 818-826.
129. Neely MD, Zimmerman L, Picklo MJ, Ou JJ, Morales CR, Montine KS et al. Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal. Free Radic Biol Med 2000; 29: 1028-1036.
130. Riahi Y, Kaiser N, Leibowitz G, Sima AV, Simionescu M, Sasson S. Mechanism of foam cell-induced endothelial cell senescence in atherosclerosis. EAS Congress Abstract book. 80th European Atherosclerosis Society Congress, 2012, p 831.
131. Hill BG, Haberzettl P, Ahmed Y, Srivastava S, Bhatnagar A. Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells. Biochem J 2008; 410: 525-534. (Pubitemid 351429023)
132. Schutt F, Bergmann M, Holz FG, Kopitz J. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003; 44: 3663-3668. (Pubitemid 36909809)
133. Krohne TU, Stratmann NK, Kopitz J, Holz FG. Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Exp Eye Res 2010; 90: 465-471.
134. Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 2005; 80: 595-606. (Pubitemid 40602960)
135. Salabei JK, Cummins TD, Singh M, Jones SP, Bhatnagar A, Hill BG. PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem J 2013; 451: 375-388.
136. Wakabayashi N, Slocum SL, Skoko JJ, Shin S, Kensler TW. When NRF2 talks, whos listening Antioxid Redox Signal 2010; 13: 1649-1663.
137. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 2002; 99: 11908-11913. (Pubitemid 34994497)
138. Levonen AL, Landar A, Ramachandran A, Ceaser EK, Dickinson DA, Zanoni G et al. Cellular mechanisms of redox cell signalling: Role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem J 2004; 378(Pt 2): 373-382. (Pubitemid 38367228)
139. Levy S, Jaiswal AK, Forman HJ. The role of c-Jun phosphorylation in EpRE activation of phase II genes. Free Radic Biol Med 2009; 47: 1172-1179.
140. Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P. Nrf2-ARE stress response mechanism: A control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res 2010; 44: 1267-1288.
141. Siow RC, Ishii T, Mann GE. Modulation of antioxidant gene expression by 4-hydroxynonenal: Atheroprotective role of the Nrf2/ARE transcription pathway. Redox Rep 2007; 12: 11-15. (Pubitemid 46210347)
142. Sporn MB, Liby KT. NRF2 and cancer: The good, the bad and the importance of context. Nat Rev Cancer 2012; 12: 564-571.
143. Awasthi YC, Ansari GA, Awasthi S. Regulation of 4-hydroxynonenal mediated signaling by glutathione S-transferases. Methods Enzymol 2005; 401: 379-407. (Pubitemid 43052405)
144. Kong D, Kotraiah V. Modulation of aldehyde dehydrogenase activity affects (/-)-4-hydroxy-2E-nonenal (HNE) toxicity and HNE-protein adduct levels in PC12 cells. J Mol Neurosci 2012; 47: 595-603.
145. Murphy TC, Amarnath V, Gibson KM, Picklo MJ Sr. Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A). J Neurochem
146. Banaclocha MM. Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases. Med Hypotheses 2001; 56: 472-477. (Pubitemid 32397880)
147. Circu ML, Aw TY. Glutathione and apoptosis. Free Radic Res 2008; 42: 689-706.
148. Vaillancourt F, Fahmi H, Shi Q, Lavigne P, Ranger P, Fernandes JC et al. 4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: The protective role of glutathione-S-transferase. Arthritis Res Ther 2008; 10: R107.
149. Gallagher EP, Huisden CM, Gardner JL. Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. Toxicol In Vitro 2007; 21: 1365-1372. (Pubitemid 350086851)
150. Li D, Hinshelwood A, Gardner R, McGarvie G, Ellis EM. Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis. Toxicology 2006; 226: 172-180. (Pubitemid 44382614)
151. Matsunaga T, Shinoda Y, Inoue Y, Endo S, El-Kabbani O, Hara A. Protective effect of rat aldo-keto reductase (AKR1C15) on endothelial cell damage elicited by 4-hydroxy-2-nonenal. Chem Biol Interact 191: 364-370.
152. Solito R, Chen CH, Mochly-Rosen D, Giachetti A, Ziche M, Donnini S. Mitochondrial aldehyde dehydrogenase-2 activation prevents beta amyloids induced endothelial cell dysfunction and restores angiogenesis. J Cell Sci 2013; 126(Pt 9): 1952-1961.
153. Pappa A, Chen C, Koutalos Y, Townsend AJ, Vasiliou V. Aldh3a1 protects human corneal epithelial cells from ultraviolet-and 4-hydroxy-2-nonenal-induced oxidative damage. Free Radic Biol Med 2003; 34: 1178-1189. (Pubitemid 36426933)
154. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 2012; 22: 66-79.
155. Ruef J, Rao GN, Li F, Bode C, Patterson C, Bhatnagar A et al. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation 1998; 97: 1071-1078.
156. Barrera G, Di Mauro C, Muraca R, Ferrero D, Cavalli G, Fazio VM et al. Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation. Exp Cell Res 1991; 197: 148-152. (Pubitemid 121006416)
157. Pizzimenti S, Laurora S, Briatore F, Ferretti C, Dianzani MU, Barrera G. Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation. Free Radic Biol Med 2002; 32: 233-245. (Pubitemid 34119402)
158. Zhang W, He Q, Chan LL, Zhou F, El Naghy M, Thompson EB et al. Involvement of caspases in 4-hydroxy-alkenal-induced apoptosis in human leukemic cells. Free Radic Biol Med 2001; 30: 699-706. (Pubitemid 32280796)
159. Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F et al. Cellular stress response: A novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 2008; 33: 2444-2471.
160. Sykiotis GP, Bohmann D. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell 2008; 14: 76-85.